top of page

Browse by category

Search

First patient treated in phase 2 obesity trial of GLY-200 polymer

First patient treated in phase 2 obesity trial of GLY-200 polymer

First patient treated in phase 2 obesity trial of GLY-200 polymer

Glyscend Therapeutics has initiated a Phase 2 clinical trial of its lead candidate, GLY-200, as a novel oral treatment for obesity....

Therapeutic polymer could provide alternative to gastric bypass

Therapeutic polymer could provide alternative to gastric bypass

Therapeutic polymer could provide alternative to gastric bypass

An orally administered therapeutic polymer, GLY-200, designed to bind to and enhance the barrier function of mucus in the...

Apnimed’s sulthiame's demonstrates efficacy in obstructive sleep apnoea

1 day ago

Magnetic field therapy mimics exercise benefiting T2DM patients living with central obesity

2 days ago

Obesity treatment in the UK risks becoming a two-tier system

2 days ago

Back to Top

bottom of page